NexCure, a company focused on CAR-T treatments, was founded by Raven and secured Series A financing led by RA Capital on March 5, 2026.
1 report, 1 independent
Updated Mar 5
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
NexCure, a company focused on CAR-T treatments, was founded by Raven and secured Series A financing led by RA Capital on March 5, 2026.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Raven
Serbian noise musician
Nothing else this week.
Coverage
Newest first; wire copies grouped- prnewswire_fairwayNexCure, Inc. Launches with $19 Million Series A Financing to enable CAR-T and other advanced treatment delivery in community outpatient settings